BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 29720199)

  • 1. Immunoassays for scarce tumour-antigens in exosomes: detection of the human NKG2D-Ligand, MICA, in tetraspanin-containing nanovesicles from melanoma.
    López-Cobo S; Campos-Silva C; Moyano A; Oliveira-Rodríguez M; Paschen A; Yáñez-Mó M; Blanco-López MC; Valés-Gómez M
    J Nanobiotechnology; 2018 May; 16(1):47. PubMed ID: 29720199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of soluble NKG2D ligands: proteolytic cleavage, exosome secretion and functional implications.
    Chitadze G; Bhat J; Lettau M; Janssen O; Kabelitz D
    Scand J Immunol; 2013 Aug; 78(2):120-9. PubMed ID: 23679194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: heterogeneous involvement of the "a disintegrin and metalloproteases" 10 and 17.
    Chitadze G; Lettau M; Bhat J; Wesch D; Steinle A; Fürst D; Mytilineos J; Kalthoff H; Janssen O; Oberg HH; Kabelitz D
    Int J Cancer; 2013 Oct; 133(7):1557-66. PubMed ID: 23526433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a rapid lateral flow immunoassay test for detection of exosomes previously enriched from cell culture medium and body fluids.
    Oliveira-Rodríguez M; López-Cobo S; Reyburn HT; Costa-García A; López-Martín S; Yáñez-Mó M; Cernuda-Morollón E; Paschen A; Valés-Gómez M; Blanco-López MC
    J Extracell Vesicles; 2016; 5():31803. PubMed ID: 27527605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer exosomes and NKG2D receptor-ligand interactions: impairing NKG2D-mediated cytotoxicity and anti-tumour immune surveillance.
    Mincheva-Nilsson L; Baranov V
    Semin Cancer Biol; 2014 Oct; 28():24-30. PubMed ID: 24602822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomes and the MICA-NKG2D system in cancer.
    Clayton A; Tabi Z
    Blood Cells Mol Dis; 2005; 34(3):206-13. PubMed ID: 15885603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural-Killer-Derived Extracellular Vesicles: Immune Sensors and Interactors.
    Federici C; Shahaj E; Cecchetti S; Camerini S; Casella M; Iessi E; Camisaschi C; Paolino G; Calvieri S; Ferro S; Cova A; Squarcina P; Bertuccini L; Iosi F; Huber V; Lugini L
    Front Immunol; 2020; 11():262. PubMed ID: 32231660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells.
    Schwinn N; Vokhminova D; Sucker A; Textor S; Striegel S; Moll I; Nausch N; Tuettenberg J; Steinle A; Cerwenka A; Schadendorf D; Paschen A
    Int J Cancer; 2009 Apr; 124(7):1594-604. PubMed ID: 19089914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated isolation and quantitative analysis of exosome shuttled proteins and nucleic acids using immunocapture approaches.
    Zarovni N; Corrado A; Guazzi P; Zocco D; Lari E; Radano G; Muhhina J; Fondelli C; Gavrilova J; Chiesi A
    Methods; 2015 Oct; 87():46-58. PubMed ID: 26044649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A GPI anchor explains the unique biological features of the common NKG2D-ligand allele MICA*008.
    Ashiru O; López-Cobo S; Fernández-Messina L; Pontes-Quero S; Pandolfi R; Reyburn HT; Valés-Gómez M
    Biochem J; 2013 Sep; 454(2):295-302. PubMed ID: 23772752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human placenta expresses and secretes NKG2D ligands via exosomes that down-modulate the cognate receptor expression: evidence for immunosuppressive function.
    Hedlund M; Stenqvist AC; Nagaeva O; Kjellberg L; Wulff M; Baranov V; Mincheva-Nilsson L
    J Immunol; 2009 Jul; 183(1):340-51. PubMed ID: 19542445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of exosomal biomarker by electric field-induced release and measurement (EFIRM).
    Tu M; Wei F; Yang J; Wong D
    J Vis Exp; 2015 Jan; (95):52439. PubMed ID: 25650727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphological and molecular features of oral fluid-derived exosomes: oral cancer patients versus healthy individuals.
    Zlotogorski-Hurvitz A; Dayan D; Chaushu G; Salo T; Vered M
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):101-10. PubMed ID: 26115960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomal tetraspanins as regulators of cancer progression and metastasis and novel diagnostic markers.
    Malla RR; Pandrangi S; Kumari S; Gavara MM; Badana AK
    Asia Pac J Clin Oncol; 2018 Dec; 14(6):383-391. PubMed ID: 29575602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The MICA-129Met/Val dimorphism affects plasma membrane expression and shedding of the NKG2D ligand MICA.
    Isernhagen A; Schilling D; Monecke S; Shah P; Elsner L; Walter L; Multhoff G; Dressel R
    Immunogenetics; 2016 Feb; 68(2):109-23. PubMed ID: 26585323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix Effect in the Isolation of Breast Cancer-Derived Nanovesicles by Immunomagnetic Separation and Electrochemical Immunosensing-A Comparative Study.
    Lima Moura S; Martì M; Pividori MI
    Sensors (Basel); 2020 Feb; 20(4):. PubMed ID: 32054015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of phosphatidylserine-positive exosomes for the diagnosis of early-stage malignancies.
    Sharma R; Huang X; Brekken RA; Schroit AJ
    Br J Cancer; 2017 Aug; 117(4):545-552. PubMed ID: 28641308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomes Derived From Natural Killer Cells Exert Therapeutic Effect in Melanoma.
    Zhu L; Kalimuthu S; Gangadaran P; Oh JM; Lee HW; Baek SH; Jeong SY; Lee SW; Lee J; Ahn BC
    Theranostics; 2017; 7(10):2732-2745. PubMed ID: 28819459
    [No Abstract]   [Full Text] [Related]  

  • 19. Interleukin 10 decreases MICA expression on melanoma cell surface.
    Serrano AE; Menares-Castillo E; Garrido-Tapia M; Ribeiro CH; Hernández CJ; Mendoza-Naranjo A; Gatica-Andrades M; Valenzuela-Diaz R; Zúñiga R; López MN; Salazar-Onfray F; Aguillón JC; Molina MC
    Immunol Cell Biol; 2011 Mar; 89(3):447-57. PubMed ID: 20714339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immuno-based detection of extracellular vesicles in urine as diagnostic marker for prostate cancer.
    Duijvesz D; Versluis CY; van der Fels CA; Vredenbregt-van den Berg MS; Leivo J; Peltola MT; Bangma CH; Pettersson KS; Jenster G
    Int J Cancer; 2015 Dec; 137(12):2869-78. PubMed ID: 26139298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.